A Phase IIb, Multicenter, Randomized, Double-Blind Placebo-Controlled, 2-Period Crossover Polysomnography Study to Evaluate Safety and Efficacy of MK4305 in Patients With Primary Insomnia.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 10 May 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

18 Mar 2014 The number of treatment arms changed from 4 to 8
10 Jun 2010 Results presented at the 24th Annual Meeting of the Associated Professional Sleep Societies (SLEEP 2010), and reported in a Merck media release.
10 Jun 2010 Primary endpoint 'Sleep efficiency' has been met.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com